Peptidomimetic Polo‐Box‐Targeted Inhibitors that Engage PLK1 in Tumor Cells and Are Selective against the PLK3 Tumor Suppressor-Reference-Cited by-同舟云学术

Peptidomimetic Polo‐Box‐Targeted Inhibitors that Engage PLK1 in Tumor Cells and Are Selective against the PLK3 Tumor Suppressor

Author:

Baxter Merissa¹²,Chapagai Danda¹,Craig Sandra¹³,Hurtado Cecilia¹⁴,Varghese Jessy¹,Nurmemmedov Elmar⁵,Wyatt Michael D.¹^ORCID,McInnes Campbell¹^ORCID

Affiliation:

1. Drug Discovery and Biomedical Sciences College of PharmacyUniversity of South Carolina Columbia SC 29208 USA

2. Present Address: NCI Shady Grove Rockville MD 20850-9702 USA

3. Present Address: Department of ChemistryWake Forest University Winston-Salem NC 27109 USA

4. Present Address: University of California San Francisco San Francisco CA 94115 USA

5. John Wayne Cancer Institute and Pacific Neuroscience Institute Providence Saint John's Health Center Santa Monica, CA USA

Funder

Memorial Sloan-Kettering Cancer Center, New York

National Institutes of Health for Funding

NIH/NCI

NIH/NCRR

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

Reference60 articles.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献